CTCBIO Inc. (KOSDAQ: 060590)

South Korea flag South Korea · Delayed Price · Currency is KRW
6,760.00
+60.00 (0.90%)
Sep 12, 2024, 11:08 AM KST
-42.81%
Market Cap 159.95B
Revenue (ttm) 134.35B
Net Income (ttm) -16.15B
Shares Out 23.91M
EPS (ttm) -673.74
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 8,098
Open 6,700.00
Previous Close 6,700.00
Day's Range 6,700.00 - 6,800.00
52-Week Range 6,050.00 - 13,970.00
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Nov 12, 2024

About CTCBIO

CTCBIO Inc. provides various pharmaceutical products in South Korea and internationally. The company offers animal and human pharmaceuticals; feed additives and ingredients; and functional food products. It also provides cardiovascular, gastrointestinal, osteoporosis, antibiotic, smoking cessation, antifungal and antiviral, antiepileptic, allergic rhinitis, dermatology and genito-urinory, allergic rhinitis and antihistamine, neuropsychiarty, intestinal disorders, X-ray, diabetes, anti-inflammatory and arthritis, and harmones, as well as CTC cov... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1993
Employees 241
Stock Exchange KOSDAQ
Ticker Symbol 060590
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.